{"id":796,"date":"2026-05-29T12:03:00","date_gmt":"2026-05-29T12:03:00","guid":{"rendered":"https:\/\/pharma-talks.com\/?post_type=episode&#038;p=796"},"modified":"2026-09-04T14:18:54","modified_gmt":"2026-09-04T14:18:54","slug":"ai-in-pharma-communication","status":"publish","type":"episode","link":"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/","title":{"rendered":"Why Western Campaign Logic Breaks in Asian Markets\u00a0"},"content":{"rendered":"\n<div style=\"height:200px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<style id=\"pharmatalks-content-section-style\">.pt-content-section{background:var(--pt-content-section-bg,transparent);color:var(--pt-content-section-text,var(--color-text));padding:var(--pt-content-section-padding-top,32px) var(--pt-content-section-padding-x,0) var(--pt-content-section-padding-bottom,32px)}.pt-content-section img{border-radius:24px}.pt-content-section>.container{max-width:var(--pt-content-section-container-max-width,var(--container-width));padding:var(--pt-content-section-container-padding-top,0) var(--pt-content-section-container-padding-x,var(--container-padding)) var(--pt-content-section-container-padding-bottom,0)}@media (max-width:899px){.pt-content-section{padding:var(--pt-content-section-mobile-padding-top,var(--pt-content-section-padding-top,32px)) var(--pt-content-section-mobile-padding-x,var(--pt-content-section-padding-x,0)) var(--pt-content-section-mobile-padding-bottom,var(--pt-content-section-padding-bottom,32px))}.pt-content-section>.container{padding:var(--pt-content-section-mobile-container-padding-top,var(--pt-content-section-container-padding-top,0)) var(--pt-content-section-mobile-container-padding-x,var(--pt-content-section-container-padding-x,var(--container-padding))) var(--pt-content-section-mobile-container-padding-bottom,var(--pt-content-section-container-padding-bottom,0))}}<\/style>\n<section class=\"wp-block-pharmatalks-content-section pt-content-section\" style=\"color:#082480;--pt-content-section-padding-top:32px;--pt-content-section-padding-bottom:32px;--pt-content-section-mobile-padding-top:16px;--pt-content-section-container-max-width:1240px;--pt-content-section-container-padding-top:0px;--pt-content-section-container-padding-bottom:0px\"><div class=\"container\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2.png\" alt=\"\" class=\"wp-image-1092\" width=\"2400\" height=\"1350\" srcset=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2.png 2400w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-300x169.png 300w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-1024x576.png 1024w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-768x432.png 768w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-1536x864.png 1536w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-2048x1152.png 2048w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-371x209.png 371w\" sizes=\"auto, (max-width: 2400px) 100vw, 2400px\" \/><\/figure>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-pharmatalks-content-section pt-content-section\" style=\"color:#082480;--pt-content-section-padding-top:32px;--pt-content-section-padding-bottom:32px;--pt-content-section-container-max-width:1280px;--pt-content-section-container-padding-top:0px;--pt-content-section-container-padding-bottom:0px\"><div class=\"container\">\n<section class=\"wp-block-pharmatalks-episode-player pt-episode-player\" style=\"color:#082480;--pt-episode-player-padding-top:0px;--pt-episode-player-padding-bottom:0px\"><div class=\"container\"><div class=\"pt-episode-player__inner\"><div class=\"pt-episode-player__media\"><img decoding=\"async\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/02\/pt-logo-1.webp\" alt=\"Don\u2019t miss a new episode\" loading=\"lazy\"\/><\/div><div class=\"pt-episode-player__content\"><p class=\"pt-episode-player__subtitle\">Why Western Campaign Logic Breaks in Asian Markets<\/p><h3 class=\"pt-episode-player__title\">Don\u2019t miss a new episode<\/h3><div class=\"pt-episode-player__controls\"><button type=\"button\" class=\"pt-episode-player__play\" aria-label=\"Play\" aria-pressed=\"false\"><span class=\"pt-episode-player__play-icon\" aria-hidden=\"true\"><\/span><\/button><div class=\"pt-episode-player__panel\"><div class=\"pt-episode-player__timeline\"><input type=\"range\" class=\"pt-episode-player__progress\" min=\"0\" max=\"100\" step=\"0.1\" defaultvalue=\"0\" aria-label=\"Seek\"\/><\/div><div class=\"pt-episode-player__bottom\"><div class=\"pt-episode-player__actions\"><button type=\"button\" class=\"pt-episode-player__speed pt-episode-player__speed--down\" data-speed=\"down\" aria-label=\"Slow down\"><span class=\"pt-episode-player__speed-icon\" aria-hidden=\"true\"><\/span><\/button><span class=\"pt-episode-player__speed-display\">1X<\/span><button type=\"button\" class=\"pt-episode-player__speed pt-episode-player__speed--up\" data-speed=\"up\" aria-label=\"Speed up\"><span class=\"pt-episode-player__speed-icon\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"pt-episode-player__time-volume\"><div class=\"pt-episode-player__volume\"><button type=\"button\" class=\"pt-episode-player__volume-toggle\" aria-label=\"Mute\" aria-pressed=\"false\"><span class=\"pt-episode-player__volume-icon\" aria-hidden=\"true\"><\/span><\/button><input type=\"range\" class=\"pt-episode-player__volume-range\" min=\"0\" max=\"1\" step=\"0.01\" defaultvalue=\"1\" aria-label=\"Volume\"\/><\/div><div class=\"pt-episode-player__time\"><span class=\"pt-episode-player__current\">0:00<\/span><span class=\"pt-episode-player__divider\">|<\/span><span class=\"pt-episode-player__duration\">&#8211;:&#8211;<\/span><\/div><\/div><\/div><\/div><\/div><div class=\"pt-episode-player__links\"><a class=\"pt-episode-player__link\" href=\"#subscribe\" rel=\"noopener noreferrer\">Subscribe<\/a><\/div><audio class=\"pt-episode-player__audio\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/08\/Pharma-Talks_-AI-in-Pharma-Communication-Breaking-the-Myths-Navigating-Asia-l-Part-1.mp3\"><\/audio><\/div><\/div><\/div><\/section>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-pharmatalks-content-section pt-content-section\" style=\"color:#082480;--pt-content-section-padding-top:32px;--pt-content-section-padding-bottom:32px;--pt-content-section-mobile-padding-x:20px;--pt-content-section-container-max-width:1200px;--pt-content-section-container-padding-top:20px;--pt-content-section-container-padding-bottom:20px;--pt-content-section-container-padding-x:20px\"><div class=\"container\" style=\"border-radius:20px;overflow:hidden;background-color:#ffffff\">\n<p class=\"wp-block-paragraph\">Half the world&#8217;s population, roughly 20% of global healthcare spending, and no two markets running the same rules. Asia&#8217;s opportunity and Asia&#8217;s difficulty are the same fact.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this episode of Pharma Talks, Nataliya Andreychuk spoke with Gwenael Meneux and Bruno Senuci of drcom about AI in regulated content work and the region most global strategies handle badly.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Gwenael spent 15 years in pharma, including six in commercial roles across Asia, before moving agency-side just over a year ago. Bruno, co-CEO and co-founder, has lived in Asia for more than 30 years \u2014 18 of them in Vietnam, where he&#8217;s based in Saigon \u2014 and focuses on operations and innovation alongside Gwenael&#8217;s more strategic, pharma-facing role.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>What AI Is Actually Doing<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Teams are using it across drafting, adaptation, translation, repurposing, and MLR readiness. But speed isn&#8217;t the objective, and &#8220;mostly accurate&#8221; doesn&#8217;t clear the bar in a regulated industry.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The question isn&#8217;t whether AI can create content, it clearly can. The question is whether that content can be trusted in a heavily regulated environment.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The gap Bruno points to is that AI can&#8217;t guarantee scientific accuracy, doesn&#8217;t reliably carry regulatory nuance, and often misses the right context or tone for a given market.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The recurring mistake is treating it as a shortcut. It&#8217;s a multiplier of whatever process already exists \u2014 which means a weak process gets scaled, not fixed. Without human oversight, quality control, compliance, and risk management all degrade at the same rate the output accelerates.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Localization Is Where This Shows<\/strong>&nbsp;<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Translation is solvable. Cultural relevance isn&#8217;t, and humans stay accountable for trust \u2014 particularly in markets with constraints on channels, operating models, and systems.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Gwenael&#8217;s read is that the current phase of AI adoption has few limits in some fields. Drug development is his example: timelines compressing from eight to ten years toward two to three, which he describes as a change of caliber.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Content production shows the limits more clearly. The value sits in summarizing, aggregating, and consolidating data \u2014 substantial help for medical affairs and marketing. Creating emotion, or adding something meaningful on top of clinical data, still requires human input. World models are evolving, but the boundary is currently palpable.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>MLR Doesn&#8217;t Get Removed<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Content can be generated fast. It still has to be validated, and that validation is a human review. AI can support and ease decisions without eliminating the step.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The companies that do well, Gwenael argues, will be the ones building at the intersection \u2014 AI-native services where human teams work alongside agents inside the workflow. Every element of the content supply chain, from localization to market-specific regulatory work, requires preparation, curated knowledge bases, and human accountability at each stage.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Nataliya raised a vision she&#8217;d heard at the Reuters US Pharma Forum: marketers speaking to an agent and watching a finished campaign appear in Salesforce Marketing Cloud. Her caution is that the black-box version is the wrong target. Trusting a model whose reasoning you can&#8217;t inspect isn&#8217;t a workflow.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Why the Region Can&#8217;t Be Clustered<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Medical need varies more inside Asia than most global plans account for. Some of the world&#8217;s oldest populations \u2014 Japan, Hong Kong, Taiwan \u2014 sit alongside some of the youngest in the Philippines, Cambodia, and India.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">That splits the disease burden. Aging markets look closer to Europe, with high cancer prevalence. Much of Southeast Asia still carries substantial communicable and infectious disease load \u2014 dengue, tuberculosis, respiratory conditions tied to air quality. &#8220;You cannot cluster these markets the same way,&#8221; Gwenael says.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Health and reimbursement systems diverge just as sharply. China runs a near-universal insurance scheme covering close to the whole population, including drugs on the national list. India&#8217;s system is highly fragmented with significant out-of-pocket cost. Access to innovative medicines differs enormously as a result, and that difference propagates into targeting, messaging, and the entire communication approach.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Launch timing adds another axis. Singapore&#8217;s early access programs can put it ahead of some European countries for certain innovations. Other markets in the region may see the same oncology or rare disease drugs three to four years later. One aligned global launch plan cannot cover that spread.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Channels and Systems Fragment Too<\/strong>&nbsp;<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Bruno&#8217;s territory. Vietnam has its own platforms. China&#8217;s internet is isolated from the rest. Thailand and Japan have distinct online behaviors. Campaign logic built around Western channels doesn&#8217;t replicate \u2014 tactics adapt market by market or they don&#8217;t work.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The fragmentation runs deeper than channels. Brands may be managed directly or through distributors. Marketing standards, execution models, and tech stacks vary widely. DAM platforms, CRMs, and approval systems \u2014 local, global, or in-house \u2014 often differ inside the same company, sometimes between HCP and healthcare communication teams. Silos follow, and integrated execution becomes much harder than an org chart suggests.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Data regulation fragments as well. Europe has the AI Act and GDPR covering most countries; in Asia each country sets its own rules. And Asian markets generally operate on smaller budgets than Europe or the US, which means adapting across more complexity with fewer resources. Bruno&#8217;s team has become expert at doing a lot with much less.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Bruno&#8217;s Framework<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Reduce friction across the full workflow, starting with an audit of local market readiness \u2014 technology, talent, regulatory stage, execution capability, budget.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">From there, build agile localization pipelines rather than one-size-fits-all content factories, which he believes have largely failed in Asia. Content needs to be easier to adapt, validate, and approve. AI reduces rework and makes drafts more review-ready, but the approval workflow has to change with it, including tiered approval.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Roadmaps should be market-specific, with tactics and execution left to local teams. They know how to do it, and don&#8217;t need global guidance at that resolution.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Technology stacks that exist at HQ frequently don&#8217;t exist locally \u2014 or exist and go underused, because local teams lack the budget, headcount, or skills to integrate them. That points to investment in local digital talent: people who understand how local platforms actually work.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">And don&#8217;t wait for the perfect model. Pilot, learn fast, fail fast where necessary, build iteratively. In Asia that beats a complex global model.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Gwenael&#8217;s Framework<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">His first warning, drawn from China: assuming what works in China works across Asia. The de-averaged view is the starting requirement.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">That said, some workable clusters aren&#8217;t geographically obvious. South Korea, Taiwan, Hong Kong, and Singapore share enough to operate together despite being scattered across the map.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">On content factories, he&#8217;s seen highly centralized global models closely, and observes a strong correlation between distance from the global decision center and how poorly equipped a market ends up. He supports regional-scale content factories with unified global templates \u2014 avoiding duplication and holding a consistent USP while clustering around ten markets rather than governing a hundred.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">His third recommendation concerns where medical budget goes. Global affiliates tend to spend much of it bringing in global KOLs or sending local KOLs to international congresses. With hindsight, he&#8217;d redirect part of that toward raising local expert voices. An Australian or US KOL may be scientifically authoritative and still have far less impact than a trusted local voice when the goal is changing practice in that community.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Talent and Test-and-Learn<\/strong>&nbsp;<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Even large pharma companies that outsource to distributors and vendors invest in a strong local expert team rather than managing everything centrally. The companies Gwenael saw succeed in China were full of local talent.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bruno treats test-and-learn as the single most important practice for Asia \u2014 more so than in Europe. He arrived in China wanting everything perfectly structured, and it didn&#8217;t work. Going in slightly imperfect and iterating beats pursuing perfection before acting.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Hot or Not<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Nataliya put statements to both guests and asked for a verdict. Several refused to stay short.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>AI will solve the localization problem in pharma.<\/strong> Bruno declines the clean answer: &#8220;It will help. It&#8217;s not a magic bullet and the answer is not entirely no. It&#8217;s in between.&#8221;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>If your content works for Europe, it will work for Asia with a good translation.<\/strong> Gwenael: &#8220;Absolutely not. Culture is even more important than language. Understanding how emotion works in Asia, in South Asia versus North Asia, is more important than translation.&#8221;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Human oversight of AI in pharma is non-negotiable.<\/strong> Bruno: &#8220;Very hot on that principle. Humans trust humans. We are not there yet at trusting machines blindly.&#8221;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Digital channel fragmentation in Asia is a competitive advantage for those who learn to navigate it.<\/strong> Gwenael: &#8220;100% hot. It requires a lot of effort and humility being surrounded by the right local experts, and also having the humility to recognise when it is not the right time to enter a particular market.&#8221;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Global pharma teams understand aging markets well enough to lead digital strategy from headquarters.<\/strong> Bruno: &#8220;Not. Absolutely not.&#8221; Global teams start from a different tech stack and different principles, skewed toward a Western ecosystem \u2014 and Asia&#8217;s fragmentation requires adaptation headquarters isn&#8217;t equipped to lead.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>The biggest barrier to AI adoption in pharma is technology.<\/strong> Gwenael: &#8220;Not. It can be a technology barrier in some cases, but the main one is human adoption and usage. It is a wide change management challenge.&#8221;&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Final Words<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Both frameworks converge on the same instruction, applied at different scales. AI multiplies what&#8217;s already there \u2014 process, content, judgment \u2014 which makes it useful to organizations that have those things and dangerous to ones that don&#8217;t.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asia applies the same logic to geography. De-average the region, invest in people who actually understand the market, and accept that a plan good enough to start with beats a plan complete enough to be late.&nbsp;<\/p>\n<\/div><\/section>\n\n\n<section class=\"pt-related-episodes\" style=\"--pt-related-bg:#264cb8;color:#082480;--pt-related-title-color:#eff2ef;--pt-related-padding-top:50px;--pt-related-padding-bottom:60px;--pt-related-padding-x:0px\">\n            <div class=\"container\">\n                        <div class=\"pt-related-episodes__header\">\n                <h2 class=\"pt-related-episodes__title\">Our Latest Pharma Talk Episodes<\/h2>\n            <\/div>\n                <div class=\"pt-related-episodes__grid\">\n                                        <article class=\"pt-episode-card\">\n                    <a class=\"pt-episode-card__image\" href=\"https:\/\/pharma-talks.com\/episodes\/podcasts-medical-affairs-leadership\/\">\n                                                    <img width=\"371\" height=\"209\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/08\/pharma-talks-real-reason-1200x675-1-371x209.png\" class=\"attachment-pharmatalks-related-card size-pharmatalks-related-card\" alt=\"\" loading=\"lazy\" decoding=\"async\" sizes=\"auto, (max-width: 640px) 100vw, (max-width: 1024px) 50vw, 371px\" srcset=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/08\/pharma-talks-real-reason-1200x675-1-371x209.png 371w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/08\/pharma-talks-real-reason-1200x675-1-300x169.png 300w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/08\/pharma-talks-real-reason-1200x675-1-1024x576.png 1024w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/08\/pharma-talks-real-reason-1200x675-1-768x432.png 768w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/08\/pharma-talks-real-reason-1200x675-1.png 1200w\" \/>                                            <\/a>\n                    <div class=\"pt-episode-card__body\">\n                        <p class=\"pt-episode-card__meta\">August 20, 2026<span class=\"pt-episode-card__duration\">6 min read<\/span><\/p>\n                        <h4 class=\"pt-episode-card__title\">\n                            <a href=\"https:\/\/pharma-talks.com\/episodes\/podcasts-medical-affairs-leadership\/\">The Real Reason Medical and Commercial Teams Stay Stuck in Silos\u00a0<\/a>\n                        <\/h4>\n                        <div class=\"pt-episode-card__detail\"><p class=\"pt-episode-card__guest-label\">Guest<\/p><p class=\"pt-episode-card__guest-name\">Laragh De Bhulbh<\/p><div class=\"pt-episode-card__guest-meta\"><p class=\"pt-episode-card__guest-meta-position\">Pharma Brand Strategist<\/p><p class=\"pt-episode-card__guest-meta-company\">WOLF MEDICAL<\/p><\/div><div class=\"pt-episode-card__actions\"><a class=\"pt-episode-card__listen\" href=\"https:\/\/pharma-talks.com\/episodes\/podcasts-medical-affairs-leadership\/\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"pt-episode-card__play-icon\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M15.3744 12.7588L14.8288 11.9208L14.8148 11.9298L14.8012 11.9394L15.3744 12.7588ZM15.3744 11.4687L14.7814 12.2739L14.826 12.3068L14.874 12.3345L15.3744 11.4687ZM10.2037 7.66122L10.7966 6.85597L10.7684 6.8352L10.7388 6.81644L10.2037 7.66122ZM9.11966 8.22991L10.1197 8.22701L10.1196 8.21826L10.1194 8.2095L9.11966 8.22991ZM9.14134 15.709L8.14134 15.7119L8.14142 15.7402L8.14311 15.7684L9.14134 15.709ZM10.2651 16.3323L10.7493 17.2072L10.7952 17.1818L10.8382 17.1517L10.2651 16.3323ZM12 21V20C7.58172 20 4 16.4183 4 12H3H2C2 17.5228 6.47715 22 12 22V21ZM21 12H20C20 16.4183 16.4183 20 12 20V21V22C17.5228 22 22 17.5228 22 12H21ZM12 3V4C16.4183 4 20 7.58172 20 12H21H22C22 6.47715 17.5228 2 12 2V3ZM12 3V2C6.47715 2 2 6.47715 2 12H3H4C4 7.58172 7.58172 4 12 4V3ZM15.3744 12.7588L15.9199 13.5969C16.3323 13.3285 16.8704 12.8393 16.8694 12.0938C16.8683 11.3258 16.3021 10.8499 15.8747 10.6029L15.3744 11.4687L14.874 12.3345C14.9677 12.3886 14.9787 12.4133 14.9586 12.3878C14.9315 12.3532 14.8696 12.2512 14.8694 12.0965C14.8692 11.9454 14.928 11.8534 14.9423 11.8342C14.952 11.821 14.9295 11.8552 14.8288 11.9208L15.3744 12.7588ZM15.3744 11.4687L15.9673 10.6634L10.7966 6.85597L10.2037 7.66122L9.61072 8.46646L14.7814 12.2739L15.3744 11.4687ZM10.2037 7.66122L10.7388 6.81644C10.286 6.52965 9.64347 6.36117 9.03218 6.6466C8.36565 6.95781 8.10714 7.62689 8.11987 8.25032L9.11966 8.22991L10.1194 8.2095C10.1185 8.16275 10.1285 8.19137 10.0938 8.25775C10.0552 8.33159 9.98183 8.41046 9.87832 8.45879C9.67864 8.55202 9.5853 8.45326 9.66854 8.50599L10.2037 7.66122ZM9.11966 8.22991L8.11966 8.23281L8.14134 15.7119L9.14134 15.709L10.1413 15.7061L10.1197 8.22701L9.11966 8.22991ZM9.14134 15.709L8.14311 15.7684C8.17339 16.2771 8.35111 16.9731 9.00854 17.3242C9.65564 17.6698 10.3249 17.4421 10.7493 17.2072L10.2651 16.3323L9.78087 15.4573C9.69245 15.5063 9.66333 15.5057 9.68777 15.5024C9.72022 15.4979 9.82562 15.4933 9.95074 15.5601C10.0775 15.6278 10.1348 15.7209 10.1513 15.7559C10.1634 15.7818 10.146 15.758 10.1396 15.6496L9.14134 15.709ZM10.2651 16.3323L10.8382 17.1517L15.9475 13.5783L15.3744 12.7588L14.8012 11.9394L9.69195 15.5128L10.2651 16.3323Z\" fill=\"#EFF2EF\"\/><\/svg><span class=\"pt-episode-card__listen-text\">Listen Now!<\/span><\/a><\/div><\/div>                    <\/div>\n                <\/article>\n                                        <article class=\"pt-episode-card\">\n                    <a class=\"pt-episode-card__image\" href=\"https:\/\/pharma-talks.com\/episodes\/future-of-pharma-content\/\">\n                                                    <img width=\"371\" height=\"209\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-371x209.png\" class=\"attachment-pharmatalks-related-card size-pharmatalks-related-card\" alt=\"\" loading=\"lazy\" decoding=\"async\" sizes=\"auto, (max-width: 640px) 100vw, (max-width: 1024px) 50vw, 371px\" srcset=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-371x209.png 371w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-300x169.png 300w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-1024x576.png 1024w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-768x432.png 768w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-1536x864.png 1536w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-2048x1152.png 2048w\" \/>                                            <\/a>\n                    <div class=\"pt-episode-card__body\">\n                        <p class=\"pt-episode-card__meta\">May 21, 2026<span class=\"pt-episode-card__duration\">8 min read<\/span><\/p>\n                        <h4 class=\"pt-episode-card__title\">\n                            <a href=\"https:\/\/pharma-talks.com\/episodes\/future-of-pharma-content\/\">Relevance, Not Volume: Tim Pantello on Pharma Content\u00a0<\/a>\n                        <\/h4>\n                        <div class=\"pt-episode-card__detail\"><p class=\"pt-episode-card__guest-label\">Guest<\/p><p class=\"pt-episode-card__guest-name\">Tim Pantello<\/p><div class=\"pt-episode-card__guest-meta\"><p class=\"pt-episode-card__guest-meta-position\">Chief Executive Officer<\/p><p class=\"pt-episode-card__guest-meta-company\">Relevate Health<\/p><\/div><div class=\"pt-episode-card__actions\"><a class=\"pt-episode-card__listen\" href=\"https:\/\/pharma-talks.com\/episodes\/future-of-pharma-content\/\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"pt-episode-card__play-icon\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M15.3744 12.7588L14.8288 11.9208L14.8148 11.9298L14.8012 11.9394L15.3744 12.7588ZM15.3744 11.4687L14.7814 12.2739L14.826 12.3068L14.874 12.3345L15.3744 11.4687ZM10.2037 7.66122L10.7966 6.85597L10.7684 6.8352L10.7388 6.81644L10.2037 7.66122ZM9.11966 8.22991L10.1197 8.22701L10.1196 8.21826L10.1194 8.2095L9.11966 8.22991ZM9.14134 15.709L8.14134 15.7119L8.14142 15.7402L8.14311 15.7684L9.14134 15.709ZM10.2651 16.3323L10.7493 17.2072L10.7952 17.1818L10.8382 17.1517L10.2651 16.3323ZM12 21V20C7.58172 20 4 16.4183 4 12H3H2C2 17.5228 6.47715 22 12 22V21ZM21 12H20C20 16.4183 16.4183 20 12 20V21V22C17.5228 22 22 17.5228 22 12H21ZM12 3V4C16.4183 4 20 7.58172 20 12H21H22C22 6.47715 17.5228 2 12 2V3ZM12 3V2C6.47715 2 2 6.47715 2 12H3H4C4 7.58172 7.58172 4 12 4V3ZM15.3744 12.7588L15.9199 13.5969C16.3323 13.3285 16.8704 12.8393 16.8694 12.0938C16.8683 11.3258 16.3021 10.8499 15.8747 10.6029L15.3744 11.4687L14.874 12.3345C14.9677 12.3886 14.9787 12.4133 14.9586 12.3878C14.9315 12.3532 14.8696 12.2512 14.8694 12.0965C14.8692 11.9454 14.928 11.8534 14.9423 11.8342C14.952 11.821 14.9295 11.8552 14.8288 11.9208L15.3744 12.7588ZM15.3744 11.4687L15.9673 10.6634L10.7966 6.85597L10.2037 7.66122L9.61072 8.46646L14.7814 12.2739L15.3744 11.4687ZM10.2037 7.66122L10.7388 6.81644C10.286 6.52965 9.64347 6.36117 9.03218 6.6466C8.36565 6.95781 8.10714 7.62689 8.11987 8.25032L9.11966 8.22991L10.1194 8.2095C10.1185 8.16275 10.1285 8.19137 10.0938 8.25775C10.0552 8.33159 9.98183 8.41046 9.87832 8.45879C9.67864 8.55202 9.5853 8.45326 9.66854 8.50599L10.2037 7.66122ZM9.11966 8.22991L8.11966 8.23281L8.14134 15.7119L9.14134 15.709L10.1413 15.7061L10.1197 8.22701L9.11966 8.22991ZM9.14134 15.709L8.14311 15.7684C8.17339 16.2771 8.35111 16.9731 9.00854 17.3242C9.65564 17.6698 10.3249 17.4421 10.7493 17.2072L10.2651 16.3323L9.78087 15.4573C9.69245 15.5063 9.66333 15.5057 9.68777 15.5024C9.72022 15.4979 9.82562 15.4933 9.95074 15.5601C10.0775 15.6278 10.1348 15.7209 10.1513 15.7559C10.1634 15.7818 10.146 15.758 10.1396 15.6496L9.14134 15.709ZM10.2651 16.3323L10.8382 17.1517L15.9475 13.5783L15.3744 12.7588L14.8012 11.9394L9.69195 15.5128L10.2651 16.3323Z\" fill=\"#EFF2EF\"\/><\/svg><span class=\"pt-episode-card__listen-text\">Listen Now!<\/span><\/a><\/div><\/div>                    <\/div>\n                <\/article>\n                                        <article class=\"pt-episode-card\">\n                    <a class=\"pt-episode-card__image\" href=\"https:\/\/pharma-talks.com\/episodes\/hcp-engagement-in-pharma\/\">\n                                                    <img width=\"371\" height=\"209\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/04\/Pharma-Talks-HCP-Engagement-in-Pharma-\u2014-Are-We-Actually-Getting-Better_-1-371x209.png\" class=\"attachment-pharmatalks-related-card size-pharmatalks-related-card\" alt=\"\" loading=\"lazy\" decoding=\"async\" sizes=\"auto, (max-width: 640px) 100vw, (max-width: 1024px) 50vw, 371px\" srcset=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/04\/Pharma-Talks-HCP-Engagement-in-Pharma-\u2014-Are-We-Actually-Getting-Better_-1-371x209.png 371w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/04\/Pharma-Talks-HCP-Engagement-in-Pharma-\u2014-Are-We-Actually-Getting-Better_-1-300x169.png 300w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/04\/Pharma-Talks-HCP-Engagement-in-Pharma-\u2014-Are-We-Actually-Getting-Better_-1-1024x576.png 1024w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/04\/Pharma-Talks-HCP-Engagement-in-Pharma-\u2014-Are-We-Actually-Getting-Better_-1-768x432.png 768w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/04\/Pharma-Talks-HCP-Engagement-in-Pharma-\u2014-Are-We-Actually-Getting-Better_-1-1536x864.png 1536w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/04\/Pharma-Talks-HCP-Engagement-in-Pharma-\u2014-Are-We-Actually-Getting-Better_-1-2048x1152.png 2048w\" \/>                                            <\/a>\n                    <div class=\"pt-episode-card__body\">\n                        <p class=\"pt-episode-card__meta\">April 29, 2026<span class=\"pt-episode-card__duration\">8 min read<\/span><\/p>\n                        <h4 class=\"pt-episode-card__title\">\n                            <a href=\"https:\/\/pharma-talks.com\/episodes\/hcp-engagement-in-pharma\/\">Your Omnichannel Problem Is Architectural<\/a>\n                        <\/h4>\n                        <div class=\"pt-episode-card__detail\"><p class=\"pt-episode-card__guest-label\">Guest<\/p><p class=\"pt-episode-card__guest-name\">Mark Watson<\/p><div class=\"pt-episode-card__guest-meta\"><p class=\"pt-episode-card__guest-meta-position\">Co-founder<\/p><p class=\"pt-episode-card__guest-meta-company\">Fractal Force<\/p><\/div><div class=\"pt-episode-card__actions\"><a class=\"pt-episode-card__listen\" href=\"https:\/\/pharma-talks.com\/episodes\/hcp-engagement-in-pharma\/\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"pt-episode-card__play-icon\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M15.3744 12.7588L14.8288 11.9208L14.8148 11.9298L14.8012 11.9394L15.3744 12.7588ZM15.3744 11.4687L14.7814 12.2739L14.826 12.3068L14.874 12.3345L15.3744 11.4687ZM10.2037 7.66122L10.7966 6.85597L10.7684 6.8352L10.7388 6.81644L10.2037 7.66122ZM9.11966 8.22991L10.1197 8.22701L10.1196 8.21826L10.1194 8.2095L9.11966 8.22991ZM9.14134 15.709L8.14134 15.7119L8.14142 15.7402L8.14311 15.7684L9.14134 15.709ZM10.2651 16.3323L10.7493 17.2072L10.7952 17.1818L10.8382 17.1517L10.2651 16.3323ZM12 21V20C7.58172 20 4 16.4183 4 12H3H2C2 17.5228 6.47715 22 12 22V21ZM21 12H20C20 16.4183 16.4183 20 12 20V21V22C17.5228 22 22 17.5228 22 12H21ZM12 3V4C16.4183 4 20 7.58172 20 12H21H22C22 6.47715 17.5228 2 12 2V3ZM12 3V2C6.47715 2 2 6.47715 2 12H3H4C4 7.58172 7.58172 4 12 4V3ZM15.3744 12.7588L15.9199 13.5969C16.3323 13.3285 16.8704 12.8393 16.8694 12.0938C16.8683 11.3258 16.3021 10.8499 15.8747 10.6029L15.3744 11.4687L14.874 12.3345C14.9677 12.3886 14.9787 12.4133 14.9586 12.3878C14.9315 12.3532 14.8696 12.2512 14.8694 12.0965C14.8692 11.9454 14.928 11.8534 14.9423 11.8342C14.952 11.821 14.9295 11.8552 14.8288 11.9208L15.3744 12.7588ZM15.3744 11.4687L15.9673 10.6634L10.7966 6.85597L10.2037 7.66122L9.61072 8.46646L14.7814 12.2739L15.3744 11.4687ZM10.2037 7.66122L10.7388 6.81644C10.286 6.52965 9.64347 6.36117 9.03218 6.6466C8.36565 6.95781 8.10714 7.62689 8.11987 8.25032L9.11966 8.22991L10.1194 8.2095C10.1185 8.16275 10.1285 8.19137 10.0938 8.25775C10.0552 8.33159 9.98183 8.41046 9.87832 8.45879C9.67864 8.55202 9.5853 8.45326 9.66854 8.50599L10.2037 7.66122ZM9.11966 8.22991L8.11966 8.23281L8.14134 15.7119L9.14134 15.709L10.1413 15.7061L10.1197 8.22701L9.11966 8.22991ZM9.14134 15.709L8.14311 15.7684C8.17339 16.2771 8.35111 16.9731 9.00854 17.3242C9.65564 17.6698 10.3249 17.4421 10.7493 17.2072L10.2651 16.3323L9.78087 15.4573C9.69245 15.5063 9.66333 15.5057 9.68777 15.5024C9.72022 15.4979 9.82562 15.4933 9.95074 15.5601C10.0775 15.6278 10.1348 15.7209 10.1513 15.7559C10.1634 15.7818 10.146 15.758 10.1396 15.6496L9.14134 15.709ZM10.2651 16.3323L10.8382 17.1517L15.9475 13.5783L15.3744 12.7588L14.8012 11.9394L9.69195 15.5128L10.2651 16.3323Z\" fill=\"#EFF2EF\"\/><\/svg><span class=\"pt-episode-card__listen-text\">Listen Now!<\/span><\/a><\/div><\/div>                    <\/div>\n                <\/article>\n                    <\/div>\n            <\/div>\n    <\/section>\n\n\n<style id=\"pharmatalks-content-split-style\">.pt-split__container.container{max-width:var(--pt-split-container-width,var(--container-width))}@media (width >= 1440px){.pt-split__container.container{overflow:hidden}}.pt-split{background-color:var(--pt-split-bg,transparent);background-repeat:var(--pt-split-bg-repeat,no-repeat);padding-bottom:var(--pt-split-padding-bottom,64px);padding-top:var(--pt-split-padding-top,64px)}.pt-split figure{margin:0}.pt-split__inner{display:flex;flex-direction:column;gap:var(--pt-split-mobile-gap,var(--pt-split-gap,120px))}@media (width >= 1440px){.pt-split__inner{margin:0 -20px}}.pt-split__inner .pt-split__col{height:fit-content}.pt-split__col--left{background-color:var(--pt-split-col-left-color,transparent);background-image:var(--pt-split-col-left-image,none);background-position:var(--pt-split-col-left-pos,center);background-repeat:var(--pt-split-col-left-repeat,no-repeat);background-size:var(--pt-split-col-left-size,auto);border-radius:var(--pt-split-col-left-border-radius,0);padding:var(--pt-split-col-left-padding-top,0) var(--pt-split-col-left-padding-right,0) var(--pt-split-col-left-padding-bottom,0) var(--pt-split-col-left-padding-left,0)}.pt-split__col--right{background-color:var(--pt-split-col-right-color,transparent);background-image:var(--pt-split-col-right-image,none);background-position:var(--pt-split-col-right-pos,center);background-repeat:var(--pt-split-col-right-repeat,no-repeat);background-size:var(--pt-split-col-right-size,auto);border-radius:var(--pt-split-col-right-border-radius,0);padding:var(--pt-split-col-right-padding-top,0) var(--pt-split-col-right-padding-right,0) var(--pt-split-col-right-padding-bottom,0) var(--pt-split-col-right-padding-left,0)}@media (min-width:998px){.pt-split__inner{gap:var(--pt-split-gap,120px)}}@media (max-width:997px){.pt-split{padding-bottom:var(--pt-split-mobile-padding-bottom,var(--pt-split-padding-bottom,64px));padding-top:var(--pt-split-mobile-padding-top,var(--pt-split-padding-top,64px))}.pt-split__col--left{padding:var(--pt-split-col-left-mobile-padding-top,var(--pt-split-col-left-padding-top,0)) var(--pt-split-col-left-mobile-padding-right,var(--pt-split-col-left-padding-right,0)) var(--pt-split-col-left-mobile-padding-bottom,var(--pt-split-col-left-padding-bottom,0)) var(--pt-split-col-left-mobile-padding-left,var(--pt-split-col-left-padding-left,0))}.pt-split__col--right{padding:var(--pt-split-col-right-mobile-padding-top,var(--pt-split-col-right-padding-top,0)) var(--pt-split-col-right-mobile-padding-right,var(--pt-split-col-right-padding-right,0)) var(--pt-split-col-right-mobile-padding-bottom,var(--pt-split-col-right-padding-bottom,0)) var(--pt-split-col-right-mobile-padding-left,var(--pt-split-col-right-padding-left,0))}.pt-split--mobile-left-top .pt-split__col--left{order:1}.pt-split--mobile-left-top .pt-split__col--right,.pt-split--mobile-right-top .pt-split__col--left{order:2}.pt-split--mobile-right-top .pt-split__col--right{order:1}.pt-split__inner .wp-block-image img{margin:0 auto}}@media (min-width:998px){.pt-split__inner{display:flex;flex-direction:row}.align-bottom .pt-split__inner{align-items:flex-end}.pt-split__col--left{flex:var(--pt-split-left-ratio,40) 1 0;min-width:0}.pt-split__col--right{flex:var(--pt-split-right-ratio,60) 1 0;max-width:var(--pt-split-right-max-width,none);min-width:0}.pt-split__col--right .pt-split__col--right-container,.pt-split__col--right>.wp-block-group__inner-container{max-width:100%}.pt-split--desktop-right-left .pt-split__col--left{order:2}.pt-split--desktop-right-left .pt-split__col--right{order:1}}<\/style>\n<section class=\"wp-block-pharmatalks-content-split pt-split pt-split--mobile-left-top pt-split--desktop-left-right\" style=\"--pt-split-gap:48px;--pt-split-padding-top:64px;--pt-split-padding-bottom:64px;--pt-split-left-ratio:28;--pt-split-right-ratio:72;--pt-split-container-width:1240px;color:#082480;--pt-split-col-left-color:#274db800;--pt-split-col-left-image:url(https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/08\/bg-pharma.png);--pt-split-col-left-size:cover;--pt-split-col-left-pos:center;--pt-split-col-left-repeat:no-repeat;--pt-split-col-left-padding-top:52px;--pt-split-col-left-padding-right:63px;--pt-split-col-left-padding-bottom:63px;--pt-split-col-left-padding-left:44px;--pt-split-col-left-border-radius:16px;--pt-split-col-right-padding-top:0px;--pt-split-col-right-padding-right:0px;--pt-split-col-right-padding-bottom:0px;--pt-split-col-right-padding-left:0px;--pt-split-col-right-border-radius:0px\"><div class=\"container pt-split__container\"><div class=\"pt-split__inner\">\n<div id=\"subscribe\" class=\"wp-block-group pt-split__col pt-split__col--left\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 class=\"wp-block-pharmatalks-split-heading pt-split-heading pt-split-heading--base pt-split-heading__inner\" style=\"--pt-split-heading-fs:56px;--pt-split-heading-fs-mobile:36px;--pt-split-heading-color:#264cb8;--pt-split-heading-mb:8px;--pt-split-heading-lh:1.2;--pt-split-heading-fw:500\">Subscribe<\/h2>\n\n\n\n<div class=\"wp-block-pharmatalks-split-text pt-split-text pt-split-text--base\" style=\"--pt-split-text-fs:18px;--pt-split-text-color:#082480;--pt-split-text-mb:24px;--pt-split-text-lh:1.2\"><div class=\"pt-split-text__inner\">To Get Pharma Talks Episodes Straight To Your Inbox.<\/div><\/div>\n\n\n\n<div class=\"wpcf7 no-js\" id=\"wpcf7-f96-o1\" lang=\"en-US\" dir=\"ltr\" data-wpcf7-id=\"96\">\n<div class=\"screen-reader-response\"><p role=\"status\" aria-live=\"polite\" aria-atomic=\"true\"><\/p> <ul><\/ul><\/div>\n<form action=\"\/?rest_route=%2Fwp%2Fv2%2Fepisode%2F796#wpcf7-f96-o1\" method=\"post\" class=\"wpcf7-form init\" id=\"96\" aria-label=\"Contact form\" novalidate=\"novalidate\" data-status=\"init\">\n<fieldset class=\"hidden-fields-container\"><input type=\"hidden\" name=\"_wpcf7\" value=\"96\" \/><input type=\"hidden\" name=\"_wpcf7_version\" value=\"6.1.6\" \/><input type=\"hidden\" name=\"_wpcf7_locale\" value=\"en_US\" \/><input type=\"hidden\" name=\"_wpcf7_unit_tag\" value=\"wpcf7-f96-o1\" \/><input type=\"hidden\" name=\"_wpcf7_container_post\" value=\"0\" \/><input type=\"hidden\" name=\"_wpcf7_posted_data_hash\" value=\"\" \/>\n<\/fieldset>\n<div class=\"notify-form\">\n\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-email\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-email wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-email\" autocomplete=\"email\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Get the latest drop\" value=\"\" type=\"email\" name=\"your-email\" \/><\/span>\n\t<\/p>\n\t<p> &nbsp;\n\t<\/p>\n\t<div class=\"acceptance\">\n\t\t<p>We use the details you submit to review your application and to contact you about appearing on PharmaTalks. If we go ahead, we will agree the terms of the recording with you separately, including the permissions we need to publish the episode. See the Privacy Policy for how we handle your data and the rights you have.\n\t\t<\/p>\n\t\t<p> &nbsp;\n\t\t<\/p>\n\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"acceptance-554\"><span class=\"wpcf7-form-control wpcf7-acceptance\"><span class=\"wpcf7-list-item\"><label><input type=\"checkbox\" name=\"acceptance-554\" value=\"1\" aria-invalid=\"false\" \/><span class=\"wpcf7-list-item-label\">I confirm I have read the <a href=\"\/privacy-policy\/\" style=\"text-decoration:underline\">Privacy Policy<\/a> and understand how Viseven Europe O\u00dc will process my personal data.<\/span><\/label><\/span><\/span><\/span><span class=\"wpcf7-form-control-wrap\" data-name=\"marketing_status\"><span class=\"wpcf7-form-control wpcf7-acceptance optional\"><span class=\"wpcf7-list-item\"><label><input type=\"checkbox\" name=\"marketing_status\" value=\"1\" aria-invalid=\"false\" \/><span class=\"wpcf7-list-item-label\">I would like to receive marketing communications from Viseven Europe O\u00dc and its Affiliates.<\/span><\/label><\/span><\/span><\/span>\n\t\t<\/p>\n\t<\/div>\n\t<p> &nbsp;\n\t<\/p>\n\t<p><span class=\"submit\"><input class=\"wpcf7-form-control wpcf7-submit has-spinner\" type=\"submit\" value=\"Notify me\" \/><\/span>\n\t<\/p>\n<\/div>\n<input class=\"wpcf7-form-control wpcf7-hidden\" value=\"Pharma Talks Newsletter\" type=\"hidden\" name=\"pageTitle\" \/>\n<input class=\"wpcf7-form-control wpcf7-hidden\" value=\"\" type=\"hidden\" name=\"pageUrl\" \/>\n<input class=\"wpcf7-form-control wpcf7-hidden\" id=\"offerType\" value=\"0\" type=\"hidden\" name=\"offerType\" \/><div class=\"wpcf7-response-output\" aria-hidden=\"true\"><\/div>\n<\/form>\n<\/div>\n\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group pt-split__col pt-split__col--right\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group pt-split__col--right-container\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<section class=\"wp-block-pharmatalks-faq pt-faq\" style=\"--pt-faq-bg:#f0f2f000;--pt-faq-text:#082480;--pt-faq-title-align:left;--pt-faq-padding-top:51px;--pt-faq-padding-bottom:64px\"><div class=\"container\"><div class=\"pt-faq__inner\"><h2 class=\"pt-faq__title\">FAQ<\/h2><div class=\"pt-faq__list\"><details class=\"pt-faq__item\"><summary class=\"pt-faq__question\">What\u00a0is\u00a0Pharma Talks about?<\/summary><div class=\"pt-faq__answer\">Pharma Talks is a\u00a0pharma\u00a0podcast\u00a0where industry leaders discuss life sciences, commercialization, tech adoption,\u00a0digital transformation,\u00a0and leadership.\u00a0<\/div><\/details><details class=\"pt-faq__item\"><summary class=\"pt-faq__question\">Who\u00a0are\u00a0Pharma Talks\u00a0for?<\/summary><div class=\"pt-faq__answer\">This\u00a0pharma\u00a0marketing\u00a0podcast\u00a0is for life sciences professionals, pharma leaders, marketers, medical teams, and innovators who want to grow and refuse to accept the industry status quo.\u00a0<\/div><\/details><details class=\"pt-faq__item\"><summary class=\"pt-faq__question\">Who is the Pharma Talks host?\u00a0<\/summary><div class=\"pt-faq__answer\">This\u00a0pharmaceutical\u00a0podcast\u00a0is hosted by Nataliya Andreychuk,\u00a0founder and CEO of\u00a0Viseven, a global company that helps life sciences brands\u00a0reach\u00a0HCPs and patients\u00a0faster with\u00a0compliant\u00a0and impactful\u00a0content. She is also a LinkedIn voice in the industry, a member of the Forbes Agency Council, and a frequent speaker at industry events. Nataliya brings more than 20 years of experience in marketing and life sciences.\u00a0<\/div><\/details><details class=\"pt-faq__item\"><summary class=\"pt-faq__question\">Can I become a guest\u00a0at\u00a0Pharma Talks?<\/summary><div class=\"pt-faq__answer\">If you have experience\u00a0in pharma\u00a0and life sciences\u00a0or have founded a\u00a0brand, platform, or media, you can apply to be a guest and share your story with our audience.\u00a0<\/div><\/details><\/div><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What\u00a0is\u00a0Pharma Talks about?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pharma Talks is a\u00a0pharma\u00a0podcast\u00a0where industry leaders discuss life sciences, commercialization, tech adoption,\u00a0digital transformation,\u00a0and leadership.\u00a0\"}},{\"@type\":\"Question\",\"name\":\"Who\u00a0are\u00a0Pharma Talks\u00a0for?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This\u00a0pharma\u00a0marketing\u00a0podcast\u00a0is for life sciences professionals, pharma leaders, marketers, medical teams, and innovators who want to grow and refuse to accept the industry status quo.\u00a0\"}},{\"@type\":\"Question\",\"name\":\"Who is the Pharma Talks host?\u00a0\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This\u00a0pharmaceutical\u00a0podcast\u00a0is hosted by Nataliya Andreychuk,\u00a0founder and CEO of\u00a0Viseven, a global company that helps life sciences brands\u00a0reach\u00a0HCPs and patients\u00a0faster with\u00a0compliant\u00a0and impactful\u00a0content. She is also a LinkedIn voice in the industry, a member of the Forbes Agency Council, and a frequent speaker at industry events. Nataliya brings more than 20 years of experience in marketing and life sciences.\u00a0\"}},{\"@type\":\"Question\",\"name\":\"Can I become a guest\u00a0at\u00a0Pharma Talks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"If you have experience\u00a0in pharma\u00a0and life sciences\u00a0or have founded a\u00a0brand, platform, or media, you can apply to be a guest and share your story with our audience.\u00a0\"}}]}<\/script><\/div><\/div><\/section>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":1092,"template":"","meta":{"pt_page_bg_color":"#eff2ef","pt_page_bg_image_id":567,"pt_page_bg_image_url":"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/04\/Rectangle-1399-4.webp","pt_page_bg_image_size":"cover","pt_page_bg_image_position":"center","pt_page_bg_image_repeat":"no-repeat","pt_page_bg_fixed":true,"pt_page_text_color":""},"episode_topic":[],"class_list":["post-796","episode","type-episode","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Asia Isn&#039;t One Market: drcom&#039;s Gwenael Meneux and Bruno Senuci<\/title>\n<meta name=\"description\" content=\"Why Western campaign logic doesn&#039;t transfer to Asia, where AI helps and where it multiplies bad process, and what de-averaging a region actually requires.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Asia Isn&#039;t One Market: drcom&#039;s Gwenael Meneux and Bruno Senuci\" \/>\n<meta property=\"og:description\" content=\"Why Western campaign logic doesn&#039;t transfer to Asia, where AI helps and where it multiplies bad process, and what de-averaging a region actually requires.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/\" \/>\n<meta property=\"og:site_name\" content=\"PharmaTalks\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-04T14:18:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/ai-in-pharma-communication\\\/\",\"url\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/ai-in-pharma-communication\\\/\",\"name\":\"Asia Isn't One Market: drcom's Gwenael Meneux and Bruno Senuci\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/ai-in-pharma-communication\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/ai-in-pharma-communication\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pharma-talks.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2.png\",\"datePublished\":\"2026-05-29T12:03:00+00:00\",\"dateModified\":\"2026-09-04T14:18:54+00:00\",\"description\":\"Why Western campaign logic doesn't transfer to Asia, where AI helps and where it multiplies bad process, and what de-averaging a region actually requires.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/ai-in-pharma-communication\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/ai-in-pharma-communication\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/ai-in-pharma-communication\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pharma-talks.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2.png\",\"contentUrl\":\"https:\\\/\\\/pharma-talks.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2.png\",\"width\":2400,\"height\":1350},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/ai-in-pharma-communication\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pharma-talks.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Episodes\",\"item\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Why Western Campaign Logic Breaks in Asian Markets\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/#website\",\"url\":\"https:\\\/\\\/pharma-talks.com\\\/\",\"name\":\"Pharmatalks dev\",\"description\":\"Exploring Pharma &amp; Life Sciences Podcasts\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-talks.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Asia Isn't One Market: drcom's Gwenael Meneux and Bruno Senuci","description":"Why Western campaign logic doesn't transfer to Asia, where AI helps and where it multiplies bad process, and what de-averaging a region actually requires.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Asia Isn't One Market: drcom's Gwenael Meneux and Bruno Senuci","og_description":"Why Western campaign logic doesn't transfer to Asia, where AI helps and where it multiplies bad process, and what de-averaging a region actually requires.","og_url":"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/","og_site_name":"PharmaTalks","article_modified_time":"2026-09-04T14:18:54+00:00","og_image":[{"width":2400,"height":1350,"url":"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/","url":"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/","name":"Asia Isn't One Market: drcom's Gwenael Meneux and Bruno Senuci","isPartOf":{"@id":"https:\/\/pharma-talks.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/#primaryimage"},"image":{"@id":"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/#primaryimage"},"thumbnailUrl":"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2.png","datePublished":"2026-05-29T12:03:00+00:00","dateModified":"2026-09-04T14:18:54+00:00","description":"Why Western campaign logic doesn't transfer to Asia, where AI helps and where it multiplies bad process, and what de-averaging a region actually requires.","breadcrumb":{"@id":"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/#primaryimage","url":"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2.png","contentUrl":"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2.png","width":2400,"height":1350},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pharma-talks.com\/"},{"@type":"ListItem","position":2,"name":"Episodes","item":"https:\/\/pharma-talks.com\/episodes\/"},{"@type":"ListItem","position":3,"name":"Why Western Campaign Logic Breaks in Asian Markets\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/pharma-talks.com\/#website","url":"https:\/\/pharma-talks.com\/","name":"Pharmatalks dev","description":"Exploring Pharma &amp; Life Sciences Podcasts","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-talks.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/pharma-talks.com\/?rest_route=\/wp\/v2\/episode\/796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-talks.com\/?rest_route=\/wp\/v2\/episode"}],"about":[{"href":"https:\/\/pharma-talks.com\/?rest_route=\/wp\/v2\/types\/episode"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharma-talks.com\/?rest_route=\/wp\/v2\/media\/1092"}],"wp:attachment":[{"href":"https:\/\/pharma-talks.com\/?rest_route=%2Fwp%2Fv2%2Fmedia&parent=796"}],"wp:term":[{"taxonomy":"episode_topic","embeddable":true,"href":"https:\/\/pharma-talks.com\/?rest_route=%2Fwp%2Fv2%2Fepisode_topic&post=796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}